Positron Emission Tomography Using [18F]-Fluorodeoxy-d-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
Top Cited Papers
- 8 April 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (8) , 1676-1688
- https://doi.org/10.1200/jco.2000.18.8.1676
Abstract
PURPOSE: To determine whether [18F]-fluorodeoxy-d-glucose ([18F]-FDG) positron emission tomography (PET) can predict the pathologic response of primary and metastatic breast cancer to chemotherapy....Keywords
This publication has 51 references indexed in Scilit:
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?European Journal Of Cancer, 1995
- Primary chemotherapy in surgically resectable breast cancerCA: A Cancer Journal for Clinicians, 1995
- Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's LymphomaJNCI Journal of the National Cancer Institute, 1995
- Breast cancer: Chemotherapy in the treatment of advanced diseaseEuropean Journal Of Cancer, 1993
- Grading Liposarcomas with PET using [18F]FDGJournal of Computer Assisted Tomography, 1990
- Positron emission tomography in patients with glioma a predictor of prognosisCancer, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- The origin of metastatic heterogeneity in tumorsPublished by Elsevier ,1981
- CARCINOMA OF THE BREASTAnnals of Surgery, 1942